Leash Biosciences is a biotechnology company focused on developing innovative therapeutic solutions using its proprietary platform for protein engineering. The company specializes in creating targeted therapies, particularly in the fields of oncology and autoimmune diseases. Leash Biosciences leverages advanced techniques to design and optimize biologics, aiming to improve treatment efficacy and patient outcomes. Their approach emphasizes precision and specificity in drug development, positioning them as a key player in the biopharmaceutical industry.